Skip to main content


Fig. 1 | Journal of Hematology & Oncology

Fig. 1

From: Immune checkpoint inhibitors of PD-L1 as cancer therapeutics

Fig. 1

The protein structures of PD-L1 and PD-1. PD-L1 and PD-1 are both transmembrane proteins that interact with each other. PD-L1 mainly contains cytoplasmic domain, transmembrane domain, and two extracellular domains IgV-like and IgC-like. Meanwhile, PD-1 protein only consists of one extracellular domain, transmembrane domain, and cytoplasmic domain

Back to article page